as on January 1, 1970 at 5:30 am IST
Check Opthea Ltd-spon Adr market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$524.8M
EPS (TTM)
0Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0EBITDA
-183.2M
Revenue (TTM)
208.9K
Profit Margin
0.00%
Return On Equity TTM
46351000.00%
Compare market cap, revenue, PE, and other key metrics of Opthea Ltd-spon Adr with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
$524.8M | NA | NA | 0.00% |
Based on 9 analysts
11.11%
Buy
33.33%
Hold
55.56%
Sell
Based on 9 analysts, 55.56% of analysts recommend a 'SELL' rating for Opthea Ltd-spon Adr. Average target price of $1.33
Get share price movements and forecasts by analysts on Opthea Ltd-spon Adr.
What analysts predicted
100%UPSIDE
Target Price
$1.33
Current Price
$
Analyzed by
9 Analysts
Target
$1.33
Opthea Ltd-spon Adr target price $1.33, a slight upside of 100% compared to current price of $. According to 9 analysts rating.
Search interest for Opthea Ltd-spon Adr Stock has increased by 125% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:125% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Organisation | Opthea Ltd-spon Adr |
Headquarters | 650 Chapel Street, South Yarra, VIC, Australia, 3141 |
Industry | Health Technology |
CEO | Dr. Frederic Guerard M.S., Pharm.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Arshad M. Khanani M.A., M.D. | Chief Medical Advisor & Chairman of Medical Advisory Board |
Ms. Jen Watts | VP Global Clinical Operations |
Ms. Karen Adams CPA | VP of Finance & Company Secretary |
Dr. Megan Baldwin M.A.I.C.D., MAICD, Ph.D. | Founder & Chief Innovation Officer |
Mr. Thomas Charles Reilly | Chief Financial Officer |
Mr. Kevin Bitter | VP of Strategy & Corporate Development |
Mr. Anand Sundaram | Vice President Marketing |
Dr. Fang Li Ph.D. | Senior Vice President of Regulatory Affairs |
Dr. Julie Clark M.D., M.S. | Senior Vice President of Clinical Development |
Dr. Frederic Guerard M.S., Pharm.D. | Chief Executive Officer |
Opthea Ltd-spon Adr market capitalisation is $0.00T as on .
Indian investors can start investing in Opthea Ltd-spon Adr (OPT) shares with as little as ₹88.042 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Opthea Ltd-spon Adr stock (as per the Rupee-Dollar exchange rate as on ).
Learn more about
fractional shares .